Divis Laboratories Ltd reported 4.15B in Cash and Equivalent for its fiscal quarter ending in March of 2025.


Cash And Equivalent Change Date
Alaunos Therapeutics USD 1.09M 592K Dec/2024
Aurobindo Pharma INR 82.35B 13.96B Mar/2025
Avita Medical AUD 14.05M 3.4M Dec/2024
Dianthus Therapeutics USD 13.24M 9.56M Jun/2025
Divis Laboratories Ltd 4.15B 31.87B Mar/2025
Ionis Pharmaceuticals USD 297.3M 33.11M Jun/2025
IQVIA Holdings USD 2.04B 299M Jun/2025
Lupin INR 31.42B 17.28B Mar/2025
Moderna USD 1.28B 344M Jun/2025
Organon & Co USD 599M 52M Jun/2025
Revvity USD 991.85M 145.77M Jun/2025
Tectonic Therapeutic USD 287.38M 146.14M Jun/2025
Tilray USD 189.7M 15.49M Nov/2024
Viatris USD 566.4M 188.6M Jun/2025
Xeris Pharmaceuticals USD 59.28M 12.34M Jun/2025